We present the case of a patient with an elevated prostate-specific antigen level who underwent a prostate MRI that revealed a mass between the prostate and rectum, prompting further evaluation.

After exciting clinical trial results, Bell Potter has maintained its rating on this exciting ASX healthcare stock.

After a routine blood test led to his diagnosis, the 70-year-old travel expert urges everyone to prioritize health exams.

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a ...

A surgeon has explained the rules men need to follow before getting tested for cancer - if they want an accurate result. March is Prostate Cancer Awareness Month as, in the UK, one in eight men are ...

Thank you for signing up! Did you know with an ad-lite subscription to Burnley Express, you get 70% fewer ads while viewing ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...